Home/Filings/4/0001416038-11-000004
4//SEC Filing

Pappert Gerald J. 4

Accession 0001416038-11-000004

CIK 0000873364other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 1:24 PM ET

Size

20.9 KB

Accession

0001416038-11-000004

Insider Transaction Report

Form 4
Period: 2011-10-14
Pappert Gerald J.
Exec. V.P., General Counsel
Transactions
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1444,5400 total
    Exercise: $73.25From: 2012-12-11Exp: 2018-12-11Common Stock (44,540 underlying)
  • Disposition to Issuer

    Common Stock

    2011-10-1475,1930 total
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1450,0000 total
    Exercise: $67.66From: 2012-05-22Exp: 2018-05-22Common Stock (50,000 underlying)
  • Disposition to Issuer

    Incentive Stock Option

    2011-10-141,7830 total
    Exercise: $56.07From: 2013-12-02Exp: 2019-12-02Common Stock (1,783 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1448,2170 total
    Exercise: $56.07From: 2013-12-02Exp: 2019-12-02Common Stock (48,217 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1448,4160 total
    Exercise: $63.11From: 2014-12-16Exp: 2020-12-16Common Stock (48,416 underlying)
  • Disposition to Issuer

    Incentive Stock Option

    2011-10-145,4600 total
    Exercise: $73.25From: 2012-12-11Exp: 2018-12-11Common Stock (5,460 underlying)
  • Disposition to Issuer

    Incentive Stock Option

    2011-10-141,5840 total
    Exercise: $63.11From: 2014-12-16Exp: 2020-12-16Common Stock (1,584 underlying)
Footnotes (4)
  • [F1]Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
  • [F2]Includes 33,750 shares of Restricted Stock with certain vesting restrictions, which restrictions lapsed under the terms of the Merger Agreement at the Effective Time of the Merger.
  • [F3]Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
  • [F4]Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.

Issuer

CEPHALON INC

CIK 0000873364

Entity typeother

Related Parties

1
  • filerCIK 0001434969

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 1:24 PM ET
Size
20.9 KB